CORDIS Highlights Microb-AI-ome’s AI Research for Early Cancer Detection

The European Commission’s CORDIS platform recently highlighted Microb-AI-ome’s innovative work on AI-enhanced colorectal cancer screening.

The article presents how the project combines microbiome analysis, artificial intelligence and federated learning technologies to improve screening precision while protecting sensitive patient data.

The feature also highlights collaboration with screening programmes, hospitals and healthcare providers across Europe to support recruitment, translational research and the future implementation of microbiome-based screening approaches.

Read CORDIS article

Why this matters

Being featured by CORDIS highlights the growing European relevance of Microb-AI-ome and its contribution to AI-driven healthcare innovation. The project demonstrates how microbiome science, federated learning and international collaboration can support more precise and privacy-conscious approaches to colorectal cancer screening and early disease detection.